Variables | n = 75 patients |
Age, yrs (mean ± SD) | 27.46 ± 17.11 (range 7 months to 80 yrs) |
Sex (male/female) | 2.26/1.0 |
Fever, n (%) | 69 (92.0%) |
Peripheral signs | |
Splenomegaly, n (%) | 35 (46.7%) |
Clubbing, n (%) | 36 (48.0%) |
Osler’s node, n (%) | 5 (6.7%) |
Roths spots, n (%) | 7 (9.3%) |
Splinter haemorrhage, n (%) | 7 (9.3%) |
Petechial haemorrhage, n (%) | 6 (8.0%) |
Janeway lesion, n (%) | 3 (4.0%) |
Complications | |
Cardiac complications | |
Congestive heart failure (CHF), n (%) | 32 (42.7%) |
Conduction abnormalities (CHB, AV block), n (%) | 5 (6.7%) |
Pericardial effusion, n (%) | 3 (4.0%) |
Neurological complications | |
CV stroke, n (%) | 15 (20.0%) |
CNS haemorrhage, n (%) | 4 (5.3%) |
Mycotic aneurysm, n (%) | 2 (2.7%) |
Encephalopathy, n (%) | 4 (5.3%) |
Renal failure, n (%) | 20 (26.7%) |
Hepatic dysfunction, n (%) | 17 (22.7%) |
Embolism | |
Brain (CV stroke), n (%) | 15 (20.0%) |
Extremities (digital infarcts), n (%) | 3 (4.0%) |
Septic pulmonary infarct, n (%) | 1 (1.3%) |
Splenic infarct, n (%) | 1 (1.3%) |
Renal infarct, n (%) | 1 (1.3%) |
Septicaemia, n (%) | 20 (26.7%) |
Laboratory parameters | |
Hemoglobin (<12 gm %), n (%) | 72 (96.0%) |
ESR (≥20 mm), n (%) | 72 (96.0%) |
Leucocytosis (>11,000/mm3), n (%) | 53 (70.7%) |
Leucopenia (<4000/mm3), n (%) | 2 (2.7%) |
Thrombocytopenia, n (%) | 21 (28.0%) |
Microscopic haematuria, n (%) | 31 (41.3%) |
Elevated CRP, n (%) | 70 (93.3%) |
Positive RA factor, n (%) | 9 (12.0%) |